Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt de Vlam

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Biomarkers in Medicine|January 15, 2016
CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitisAnne Sofie Siebuhr, Anne C Bay-Jensen, Morten Asser Karsdal, et al.
Clinical and Experimental Rheumatology|December 24, 2014
Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trialBruce Kirkham, Kurt de Vlam, Wenzhi Li, et al.
Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|September 2, 2019
Multi-segment spine and hip kinematics in asymptomatic individuals during standardized return from forward bending versus functional box liftingStefan F L Seerden, Wim Dankaerts, Thijs W Swinnen, et al.
Clinical Biomechanics (Bristol, Avon)|April 27, 2021
Axial Spondyloarthritis is associated with changes in lumbosacral loading during daily activitiesStefan F L Seerden, Wim Dankaerts, Thijs W Swinnen, et al.
Frontiers in Immunology|March 11, 2024
Pain in axial spondyloarthritis: role of the JAK/STAT pathwayCarlo Selmi, Maria Sole Chimenti, Lucia Novelli, et al.
RMD Open|January 8, 2025
Low apolipoprotein A1 and high apolipoprotein B levels indicate specific lipid changes in treatment naïve early psoriatic arthritisAlla Ishchenko, M Van Mechelen, Lies Storms, et al.
RMD Open|September 24, 2025
Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive proteinAlla Ishchenko, Margot Van Mechelen, Sofia Pazmino, et al.
The Journal of Rheumatology|February 16, 2021
GRAPPA 2019 Research Recipient Awards ReportArthur Kavanaugh, Alla Ishchenko, Rik J Lories, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
GRAPPA 2019 Research Recipient Awards ReportArthur Kavanaugh, Alla Ishchenko, Rik J Lories, et al.
Rheumatology (Oxford, England)|March 12, 2021
The burden of psoriatic arthritis in the biologics era: data from the Belgian Epidemiological Psoriatic Arthritis StudyKurt de Vlam, Serge Steinfeld, Adrien Nzeusseu Toukap, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Biomarkers in Medicine|January 15, 2016
CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitisAnne Sofie Siebuhr, Anne C Bay-Jensen, Morten Asser Karsdal, et al.
Clinical and Experimental Rheumatology|December 24, 2014
Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trialBruce Kirkham, Kurt de Vlam, Wenzhi Li, et al.
Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|September 2, 2019
Multi-segment spine and hip kinematics in asymptomatic individuals during standardized return from forward bending versus functional box liftingStefan F L Seerden, Wim Dankaerts, Thijs W Swinnen, et al.
Clinical Biomechanics (Bristol, Avon)|April 27, 2021
Axial Spondyloarthritis is associated with changes in lumbosacral loading during daily activitiesStefan F L Seerden, Wim Dankaerts, Thijs W Swinnen, et al.
Frontiers in Immunology|March 11, 2024
Pain in axial spondyloarthritis: role of the JAK/STAT pathwayCarlo Selmi, Maria Sole Chimenti, Lucia Novelli, et al.
RMD Open|January 8, 2025
Low apolipoprotein A1 and high apolipoprotein B levels indicate specific lipid changes in treatment naïve early psoriatic arthritisAlla Ishchenko, M Van Mechelen, Lies Storms, et al.
RMD Open|September 24, 2025
Serum calprotectin and complement factor C3 are superior biomarkers of inflammation in early psoriatic arthritis as compared with C-reactive proteinAlla Ishchenko, Margot Van Mechelen, Sofia Pazmino, et al.
The Journal of Rheumatology|February 16, 2021
GRAPPA 2019 Research Recipient Awards ReportArthur Kavanaugh, Alla Ishchenko, Rik J Lories, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
GRAPPA 2019 Research Recipient Awards ReportArthur Kavanaugh, Alla Ishchenko, Rik J Lories, et al.
Rheumatology (Oxford, England)|March 12, 2021
The burden of psoriatic arthritis in the biologics era: data from the Belgian Epidemiological Psoriatic Arthritis StudyKurt de Vlam, Serge Steinfeld, Adrien Nzeusseu Toukap, et al.
Pageof 14